A rare family of SMA combined with type B Kufs disease

Ethics approval

This study involves human participants and was approved by the Ethics Committee of The Second Hospital, Lanzhou University (2024 A-636). Participants gave informed consent to participate in the study before participation.

Patient consent for publication

Consent obtained directly from the patients.

Competing interests

None declared.

留言 (0)

沒有登入
gif